HPGC Renmintongtai Pharmaceutical Corp Cash Flow-to-Debt Ratio
HPGC Renmintongtai Pharmaceutical Corp cash flow-to-debt ratio. HPGC Renmintongtai Pharmaceutical Corp (600829) has a Cash Flow-to-Debt Ratio of -0.05x as of September 2025, meaning its operating cash flow of CN¥-187.38 Million could theoretically repay 0% of its total liabilities (CN¥4.03 Billion) in one year. Check 600829 cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of HPGC Renmintongtai Pharmaceutical Corp (1998–2025)
Cash flow-to-debt ratio of HPGC Renmintongtai Pharmaceutical Corp from 1998 to 2025. Historical debt coverage capacity for HPGC Renmintongtai Pharmaceutical Corp across 28 annual periods. Check cash flow reinvestment rate of HPGC Renmintongtai Pharmaceutical Corp to assess the company's total reinvestment commitment from operating cash flow.
HPGC Renmintongtai Pharmaceutical Corp Cash Flow-to-Debt Ratio by Year (1998–2025)
HPGC Renmintongtai Pharmaceutical Corp cash flow-to-debt ratio by year from 1998 to 2025. Year-by-year debt coverage analysis for HPGC Renmintongtai Pharmaceutical Corp. For the full cash flow conversion analysis, see HPGC Renmintongtai Pharmaceutical Corp cash conversion from operations.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.07x | CN¥299.98 Million | CN¥4.16 Billion | ▲ +167.7% |
| 2024 | 0.03x | CN¥115.44 Million | CN¥4.29 Billion | ▼ -62.2% |
| 2023 | 0.07x | CN¥332.99 Million | CN¥4.68 Billion | ▲ +6.5% |
| 2022 | 0.07x | CN¥307.33 Million | CN¥4.60 Billion | ▲ +230.5% |
| 2021 | -0.05x | CN¥-233.00 Million | CN¥4.55 Billion | ▼ -2123.4% |
| 2020 | 0.00x | CN¥-9.22 Million | CN¥4.00 Billion | ▲ +97.9% |
| 2019 | -0.11x | CN¥-411.60 Million | CN¥3.70 Billion | ▼ -186.0% |
| 2018 | 0.13x | CN¥366.45 Million | CN¥2.83 Billion | ▲ +200.4% |
| 2017 | 0.04x | CN¥139.07 Million | CN¥3.23 Billion | ▲ +196.0% |
| 2016 | 0.01x | CN¥46.01 Million | CN¥3.16 Billion | ▼ -87.8% |
| 2015 | 0.12x | CN¥333.99 Million | CN¥2.81 Billion | ▼ -65.8% |
| 2014 | 0.35x | CN¥392.58 Million | CN¥1.13 Billion | ▲ +417.2% |
| 2013 | -0.11x | CN¥-158.31 Million | CN¥1.44 Billion | ▼ -186.4% |
| 2012 | 0.13x | CN¥221.57 Million | CN¥1.75 Billion | ▲ +323.6% |
| 2011 | -0.06x | CN¥-108.30 Million | CN¥1.91 Billion | ▼ -155.1% |
| 2010 | 0.10x | CN¥162.99 Million | CN¥1.58 Billion | ▼ -72.5% |
| 2009 | 0.37x | CN¥447.82 Million | CN¥1.20 Billion | ▲ +818.3% |
| 2008 | -0.05x | CN¥-65.93 Million | CN¥1.27 Billion | ▼ -134.7% |
| 2007 | 0.15x | CN¥191.10 Million | CN¥1.27 Billion | ▼ -9.3% |
| 2006 | 0.17x | CN¥191.13 Million | CN¥1.16 Billion | ▼ -41.9% |
| 2005 | 0.28x | CN¥313.04 Million | CN¥1.10 Billion | ▲ +288.0% |
| 2004 | 0.07x | CN¥60.69 Million | CN¥828.09 Million | ▼ -47.2% |
| 2003 | 0.14x | CN¥71.65 Million | CN¥516.46 Million | ▼ -56.1% |
| 2002 | 0.32x | CN¥127.49 Million | CN¥403.72 Million | ▲ +881.2% |
| 2001 | 0.03x | CN¥14.79 Million | CN¥459.59 Million | ▼ -72.2% |
| 2000 | 0.12x | CN¥61.85 Million | CN¥534.74 Million | ▼ -42.9% |
| 1999 | 0.20x | CN¥58.21 Million | CN¥287.56 Million | ▲ +19.4% |
| 1998 | 0.17x | CN¥41.00 Million | CN¥241.76 Million | — |